All Relations between Muscle Weakness and dmd
| Publication | Sentence | Publish Date | Extraction Date | Species |
|---|---|---|---|---|
| M Saitoh, H Miyakoda, H Kitamura, S Kasagi, H Takakur. [Clinical significance of serum cardiac myosin light chain I in patients with muscular dystrophy]. Rinsho shinkeigaku = Clinical neurology. vol 30. issue 8. 1991-01-24. PMID:2253417. | all patients with dmd and fcmd showed moderate or severe skeletal muscle weakness. | 1991-01-24 | 2023-08-11 | human |
| O Kikumoto, J Yoshinaga, T Sasaki, H Ideshita, A Hikiji, K Arahat. [A manifesting carrier of Duchenne muscular dystrophy presenting mosaic distribution of dystrophin negative and positive muscle fibers]. Rinsho shinkeigaku = Clinical neurology. vol 30. issue 1. 1990-06-05. PMID:2184962. | a 25-year-old female patient with an approximate 10-year-history of slowly progressive muscle weakness was diagnosed as a manifesting carrier of duchenne muscular dystrophy (dmd) because her muscle biopsy showed scattered fibers with no dystrophin on immunohistochemical staining. | 1990-06-05 | 2023-08-11 | Not clear |
| F J Curran, A P Colber. Ventilator management in Duchenne muscular dystrophy and postpoliomyelitis syndrome: twelve years' experience. Archives of physical medicine and rehabilitation. vol 70. issue 3. 1989-04-17. PMID:2647055. | after the onset of respiratory failure, patients with dmd continued to show a classic course of progressive, generalized muscle weakness and a steadily declining vital capacity from an average of 482ml to 336ml. | 1989-04-17 | 2023-08-11 | Not clear |